Results from the Survey of Antibiotic Resistance (SOAR) 2020–21 in Vietnam: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkaf290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Didem Torumkuney und 6 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Research Unit, GSK, London, UK. Hauptthemen laut MEDLINE: Streptococcus pneumoniae, Anti-Bacterial Agents, Haemophilus influenzae, Drug Resistance, Bacterial. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GSK.
Abstract (Originalsprache)
Objectives
Antibiotic susceptibility determination of Streptococcus pneumoniae and Haemophilus influenzae from community-acquired respiratory infections collected in 2020–21 from two hospitals in Ho Chi Minh City, Vietnam.
Methods
MICs were determined by CLSI broth microdilution; susceptibility was interpreted based on CLSI, EUCAST and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
Results
A total of 144 S. pneumoniae and 191 H. influenzae isolates were collected. S. pneumoniae susceptibility to amoxicillin and amoxicillin/clavulanic acid (2:1) was 56.9% and 56.3% (CLSI), 29.2% and 25.7% (EUCAST high-dose) and 78.5% using high-dose amoxicillin (4 g/0.25 g/day, PK/PD). Susceptibility to ceftriaxone was 91.7% by EUCAST (high-dose) and 50.7% by CLSI or PK/PD. Pneumococcal cefotaxime susceptibility was 61.8% by CLSI (29.9%, EUCAST). Penicillin susceptibility was 69.4% by CLSI intravenous/EUCAST high-dose, but 6.3% using CLSI oral/EUCAST low-dose breakpoints. Tetracyclines, macrolides and trimethoprim/sulfamethoxazole had 5.6%–16.7% susceptibility. Among H. influenzae isolates, 59.7% were β-lactamase-negative, of which 87.7% and 74.6% were ampicillin-resistant (BLNAR) following EUCAST and CLSI criteria, respectively. H. influenzae fluoroquinolone, macrolide and tetracycline susceptibility reached 62.0%–89.5% (CLSI, EUCAST); macrolide susceptibility was 3.7%–5.8% (PK/PD). All were susceptible to ceftriaxone (all breakpoints) and cefotaxime (CLSI, PK/PD); cefotaxime susceptibility was 15.7% by EUCAST. H. influenzae amoxicillin/clavulanic acid susceptibility was 45.5% (EUCAST) and 32.5% (CLSI) but increased to 82.8% with high-dose (4 g/0.25 g/day, PK/PD).
Conclusions
The hospitals showed high rates of penicillin-resistant S. pneumoniae and BLNAR H. influenzae. S. pneumoniae showed low susceptibility to macrolides and several cephalosporins. H. influenzae fluoroquinolone susceptibility was 88.0%–89.0% (CLSI). Future surveillance across Vietnam will help understand susceptibility trends over time and regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Research Unit, GSK, London, UK.
- Department of Microbiology, Vietnam Research and Development Institute of Clinical Microbiology (VCM), Ho Chi Minh City, Vietnam.
- Pediatric Department, Pediatric 1 Hospital, Ho Chi Minh City, Vietnam.
- Global Affairs, IHMA Europe Sàrl, Monthey, Switzerland.
- Infectious Diseases - Antibiotic Resistance, GSK, Singapore, Republic of Singapore.
- Vaccine Department, GSK, Ho Chi Minh City, Vietnam.
Förderung
- GSK
Zitieren
APA
Torumkuney, D., Van, P. H., Thinh, L. Q., Hawser, S., Kundu, S., Truong Ha Lan, N., & Manoharan, A. (2025). Results from the Survey of Antibiotic Resistance (SOAR) 2020–21 in Vietnam: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf290
Vancouver
Torumkuney D, Van PH, Thinh LQ, Hawser S, Kundu S, Truong Ha Lan N, et al. Results from the Survey of Antibiotic Resistance (SOAR) 2020–21 in Vietnam: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf290
BibTeX
@article{Torumkuney2025,
author = {Torumkuney, Didem and Van, Pham Hung and Thinh, Le Quoc and Hawser, Stephen and Kundu, Subhashri and Truong Ha Lan, Ngoc and Manoharan, Anand},
title = {Results from the Survey of Antibiotic Resistance (SOAR) 2020–21 in Vietnam: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkaf290}
}
EUVIMED